Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01495481 · ClinicalTrials.gov registry record · NA
Dexmedetomidine and Adenosine: Therapeutic Use for SVT
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01495481 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 22 participants.
The verdict
NCT01495481, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).
Interventions
- DRUG Dexmedetomidine
- DRUG Adenosine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01495481
The ClinicalTrials.gov registry entry for NCT01495481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT01495481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01495481 about?
NCT01495481 is a clinical study titled "Dexmedetomidine and Adenosine: Therapeutic Use for SVT". The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).
What is the current status of trial NCT01495481?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01495481?
The interventions under investigation include: Dexmedetomidine (DRUG), Adenosine (DRUG).
Who is sponsoring clinical trial NCT01495481?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.